市場調査レポート

商品コード

1652019

ワクチンアジュバントの世界市場：市場規模・シェア・動向、業界分析 (製品種類別・投与経路別・疾患の種類別・用途別・地域別)、将来予測 (2025年～2034年)

Vaccine Adjuvants Market Size, Share, Trends, Industry Analysis Report: By Product Type, Route of Administration, Disease Type, Application, and Region - Market Forecast, 2025-2034

出版日: 2025年01月01日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 610,172円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 753,742円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 897,312円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のワクチンアジュバント市場規模は2034年までに60億3,504万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ワクチンアジュバント市場には、免疫反応を高めるためにワクチンに添加される物質が含まれます。これらのアジュバントは、特に課題疾患に対するワクチンの有効性を向上させます。ワクチン需要の増加、アジュバント技術の進歩、予防接種に対する意識の高まりが市場成長の原動力となっています。主な企業は、安全性と有効性を改善した新しいアジュバントの開発に注力しています。ワクチン接種プログラムの増加や、COVID-19をはじめとする新興疾患に対するワクチンの必要性が、市場を後押ししています。

ワクチンアジュバント市場の成長は、特に感染症やがん免疫療法に対する効果的なワクチン需要の増加によってもたらされます。主な促進要因としては、世界の感染症罹患率の上昇、ワクチンの有効性向上に対するニーズの高まり、ワクチン開発に対する政府および民間セクターの継続的な投資が挙げられます。ワクチンアジュバントの市場開拓のチャンスは、より優れた安全性プロファイルを持つ次世代アジュバントの開発と、がんワクチンを含む個別化医療におけるアジュバントの使用の拡大にあります。市場動向には、リポソームベースやサポニンベースのアジュバントなど、より高度なアジュバント技術へのシフトや、新たな健康脅威に対応したワクチン研究の拡大が含まれます。全体として、同市場は技術革新、戦略的提携、世界の医療ニーズの高まりに支えられ、着実に成長する態勢を整えています。

ワクチンアジュバント市場：分析概要

製品種類別に見ると、ミョウバン分野は、ワクチンへの長年の使用と実証された安全性により、最大の市場シェアを占めています。しかし、アジュバントエマルションは、感染症やパンデミックのワクチンにおける免疫反応の強化に牽引され、最も急成長している分野です。

投与経路別では、インフルエンザやCOVID-19など様々な感染症向けワクチンで広く使用されている筋肉内投与経路が市場を独占しています。皮下投与は、特に治療用ワクチンや免疫療法への応用において最も高い成長を示しています。

疾患の種類別では、インフルエンザ、肝炎、COVID-19などの疾病に対する現在進行中のワクチン接種プログラムによって、感染症分野がワクチンアジュバント市場の売上シェアを独占しています。がん分野は、免疫療法ワクチンや個別化医療の進歩に後押しされ、最も高い成長を遂げています。

アジュバントを添加したワクチンが世界の公衆衛生活動で広く使用されていることから、用途別では商業用途分野がワクチンアジュバント市場シェアをリードしています。研究用途分野は、ワクチン開発と臨床試験、特にがんワクチンと治療用ワクチンへの投資の増加に支えられ、最も急速に成長しています。

北米は、強力な医療インフラと充実したワクチン研究投資により、最大の市場シェアを占めています。アジア太平洋は、医療ニーズの拡大、人口の増加、ワクチン採用の増加により、最も高い成長を示しています。

市場スナップショット
ワクチンアジュバントの市場力学
- 促進要因と機会
  - 先進的なアジュバント技術への注目の高まり
  - パンデミック対策におけるアジュバントの役割の拡大
  - 個別化ワクチンアジュバント戦略の拡大
- 抑制要因と課題
  - 規制上の課題
PESTLE分析
ワクチンアジュバント市場の動向
バリューチェーン分析
COVID-19の影響分析

第5章世界のワクチンアジュバント市場：製品種類別

主な調査結果
イントロダクション
微粒子アジュバント
アジュバントエマルジョン
病原体成分
ミョウバン
その他

第6章世界のワクチンアジュバント市場：投与経路別

主な調査結果
イントロダクション
筋肉内投与
皮下投与
その他

第7章世界のワクチンアジュバント市場：疾患の種類別

主な調査結果
イントロダクション
感染症
がん
その他

第8章世界のワクチンアジュバント市場：用途別

主な調査結果
イントロダクション
研究用途
商業用途

第9章世界のワクチンアジュバント市場：地域別

主な調査結果
イントロダクション
- ワクチンアジュバント市場の評価：地域別 (2020～2034年)
北米
- 北米：製品種類別 (2020～2034年)
- 北米：投与経路別 (2020～2034年)
- 北米：用途別 (2020～2034年)
- 北米：疾患の種類別 (2020～2034年)
- 米国
- カナダ
欧州
- 欧州：製品種類別 (2020～2034年)
- 欧州：投与経路別 (2020～2034年)
- 欧州：用途別 (2020～2034年)
- 欧州：疾患の種類別 (2020～2034年)
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：製品種類別 (2020～2034年)
- アジア太平洋：投与経路別 (2020～2034年)
- アジア太平洋：用途別 (2020～2034年)
- アジア太平洋：疾患の種類別 (2020～2034年)
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：製品種類別 (2020～2034年)
- 中東・アフリカ：投与経路別 (2020～2034年)
- 中東・アフリカ：用途別 (2020～2034年)
- 中東・アフリカ：疾患の種類別 (2020～2034年)
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：製品種類別 (2020～2034年)
- ラテンアメリカ：投与経路別 (2020～2034年)
- ラテンアメリカ：用途別 (2020～2034年)
- ラテンアメリカ：疾患の種類別 (2020～2034年)
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第10章競合情勢

事業拡大・企業買収の分析
- 事業拡大
- 企業買収
提携/協業/合意/公開

第11章企業プロファイル

GlaxoSmithKline（GSK）
Novavax
Merck & Co.
Sanofi
CSL Limited
Adjuvance Technologies
SEPPIC
Croda International
Vaxine Pty Ltd
Brenntag Biosector
Vaccitech（University of Oxford spin-off）
Emergent BioSolutions
Avanti Polar Lipids
Daiichi Sankyo
ImmunoScience

図表

List of Tables:

Table 1 Global Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 2 Global Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 3 Global Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 4 Global Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 5 North America: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 6 North America: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 7 North America: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 8 North America: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 9 U.S.: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 10 U.S.: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 11 U.S.: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 12 U.S.: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 13 Canada: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 14 Canada: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 15 Canada: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 16 Canada: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 17 Europe: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 18 Europe: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 19 Europe: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 20 Europe: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 21 UK: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 22 UK: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 23 UK: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 24 UK: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 25 France: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 26 France: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 27 France: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 28 France: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 29 Germany: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 30 Germany: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 31 Germany: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 32 Germany: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 33 Italy: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 34 Italy: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 35 Italy: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 36 Italy: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 37 Spain: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 38 Spain: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 39 Spain: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 40 Spain: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 41 Netherlands: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 42 Netherlands: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 43 Netherlands: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 44 Netherlands: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 45 Russia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 46 Russia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 47 Russia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 48 Russia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 49 Rest of Europe: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 50 Rest of Europe: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 51 Rest of Europe: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 52 Rest of Europe: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 53 Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 54 Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 55 Asia Pacific: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 56 Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 57 China: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 58 China: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 59 China: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 60 China: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 61 India: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 62 India: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 63 India: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 64 India: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 65 Malaysia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 66 Malaysia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 67 Malaysia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 68 Malaysia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 69 Japan: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 70 Japan: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 71 Japan: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 72 Japan: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 73 Indonesia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 74 Indonesia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 75 Indonesia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 76 Indonesia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 77 South Korea: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 78 South Korea: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 79 South Korea: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 80 South Korea: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 81 Australia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 82 Australia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 83 Australia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 84 Australia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 85 Rest of Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 86 Rest of Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 87 Rest of Asia Pacific: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 88 Rest of Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 89 Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 90 Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 91 Middle East & Africa: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 92 Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 93 Saudi Arabia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 94 Saudi Arabia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 95 Saudi Arabia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 96 Saudi Arabia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 97 UAE: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 98 UAE: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 99 UAE: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 100 UAE: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 101 Israel: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 102 Israel: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 103 Israel: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 104 Israel: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 105 South Africa: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 106 South Africa: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 107 South Africa: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 108 South Africa: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 109 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 110 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 111 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 112 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 113 Latin America: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 114 Latin America: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 115 Latin America: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 116 Latin America: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 117 Mexico: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 118 Mexico: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 119 Mexico: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 120 Mexico: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 121 Brazil: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 122 Brazil: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 123 Brazil: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 124 Brazil: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 125 Argentina: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 126 Argentina: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 127 Argentina: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 128 Argentina: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
Table 129 Rest of Latin America: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
Table 130 Rest of Latin America: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
Table 131 Rest of Latin America: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
Table 132 Rest of Latin America: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Vaccine Adjuvants Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product Type
Figure 7. Global Vaccine Adjuvants Market, by Product Type, 2024 & 2034 (USD Million)
Figure 8. Market by Route of Administration
Figure 9. Global Vaccine Adjuvants Market, by Route of Administration, 2024 & 2034 (USD Million)
Figure 10. Market by Application
Figure 11. Global Vaccine Adjuvants Market, by Application, 2024 & 2034 (USD Million)
Figure 12. Market by Disease Type
Figure 13. Global Vaccine Adjuvants Market, by Disease Type, 2024 & 2034 (USD Million)

Product Code: PM1684

The global vaccine adjuvants market size is expected to reach USD 6,035.04 million by 2034, according to a new study by Polaris Market Research. The report "Vaccine Adjuvants Market Size, Share, Trends, Industry Analysis Report: By Product Type (Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Alum, and Others), Route of Administration, Disease Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The vaccine adjuvants market involves substances added to vaccines to enhance immune responses. These adjuvants improve the efficacy of vaccines, particularly for challenging diseases. Growing demand for vaccines, advancements in adjuvant technologies, and increased awareness of immunization are driving market growth. Key players focus on developing new adjuvants with improved safety and effectiveness. The market is fueled by rising vaccination programs and the need for vaccines against emerging diseases, including COVID-19.

The vaccine adjuvants market growth is driven by the increasing demand for effective vaccines, particularly for infectious diseases and cancer immunotherapy. Key drivers include the rising incidence of infectious diseases across the world, increasing need for enhanced vaccine efficacy, and continued government and private sector investments in vaccine development. Vaccine adjuvants market opportunities lie in the development of next-generation adjuvants with better safety profiles and the growing use of adjuvants in personalized medicine, including cancer vaccines. Market trends include a shift toward more advanced adjuvant technologies, such as liposome-based and saponin-based adjuvants, and the expansion of vaccine research in response to emerging health threats. Overall, the market is poised for steady growth, supported by innovation, strategic collaborations, and increasing healthcare needs worldwide.

Vaccine Adjuvants Market Report Highlights

Based on product type, the alum segment holds the largest market share due to its long-standing use in vaccines and proven safety. However, adjuvant emulsions are the fastest-growing segment, driven by their enhanced immune response in vaccines for infectious diseases and pandemics.

By route of administration, the intramuscular route segment dominates the market due to its widespread use in vaccines for various infectious diseases, such as influenza and COVID-19. The subcutaneous route is registering the highest growth, particularly in therapeutic vaccines and immunotherapy applications.

In terms of disease type, the infectious diseases segment dominates the vaccine adjuvants market revenue share, driven by ongoing vaccination programs for diseases such as influenza, hepatitis, and COVID-19. The cancer segment is experiencing the highest growth, fueled by advancements in immunotherapy vaccines and personalized medicine.

The commercial application segment, by application, leads the vaccine adjuvants market share owing to the widespread use of adjuvanted vaccines in public health initiatives globally. The research application segment is growing the fastest, supported by increased investments in vaccine development and clinical trials, especially in cancer and therapeutic vaccines.

North America holds the largest market share due to its strong healthcare infrastructure and substantial vaccine research investments. Asia Pacific is registering the highest growth, driven by expanding healthcare needs, large populations, and increasing vaccine adoption.

Polaris Market Research has segmented the vaccine adjuvants market report on the basis of product type, route of administration, disease type, application, and region:

By Product Type Outlook (Revenue - USD Million, 2020-2034)

Particulate Adjuvants
Adjuvant Emulsions
Pathogen Components
Alum
Others

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

Intramuscular Route
Subcutaneous Route
Others

By Disease Type Outlook (Revenue - USD Million, 2020-2034)

Infectious Diseases
Cancer
Others

By Application Outlook (Revenue - USD Million, 2020-2034)

Research Application
Commercial Application

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Vaccine Adjuvants Market Insights

4.1. Vaccine Adjuvants Market - Market Snapshot
4.2. Vaccine Adjuvants Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Focus on Advanced Adjuvant Technologies
  - 4.2.1.2. Growing Role of Adjuvants in Pandemic Preparedness
  - 4.2.1.3. Expansion of Personalized Vaccine Adjuvant Strategies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory Challenges
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Vaccine Adjuvants Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Vaccine Adjuvants Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
5.3. Particulate Adjuvants
- 5.3.1. Global Vaccine Adjuvants Market, by Particulate Adjuvants, by Region, 2020-2034 (USD Million)
5.4. Adjuvant Emulsions
- 5.4.1. Global Vaccine Adjuvants Market, by Adjuvant Emulsions, by Region, 2020-2034 (USD Million)
5.5. Pathogen Components
- 5.5.1. Global Vaccine Adjuvants Market, by Pathogen Components, by Region, 2020-2034 (USD Million)
5.6. Alum
- 5.6.1. Global Vaccine Adjuvants Market, by Alum, by Region, 2020-2034 (USD Million)
5.7. Others
- 5.7.1. Global Vaccine Adjuvants Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Vaccine Adjuvants Market, by Route of Administration

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
6.3. Intramuscular Route
- 6.3.1. Global Vaccine Adjuvants Market, by Intramuscular Route, by Region, 2020-2034 (USD Million)
6.4. Subcutaneous Route
- 6.4.1. Global Vaccine Adjuvants Market, by Subcutaneous Route, by Region, 2020-2034 (USD Million)
6.5. Others
- 6.5.1. Global Vaccine Adjuvants Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Vaccine Adjuvants Market, by Disease Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
7.3. Infectious Diseases
- 7.3.1. Global Vaccine Adjuvants Market, by Infectious Diseases, by Region, 2020-2034 (USD Million)
7.4. Cancer
- 7.4.1. Global Vaccine Adjuvants Market, by Cancer, by Region, 2020-2034 (USD Million)
7.5. Others
- 7.5.1. Global Vaccine Adjuvants Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Vaccine Adjuvants Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
8.3. Research Application
- 8.3.1. Global Vaccine Adjuvants Market, by Research Application, by Region, 2020-2034 (USD Million)
8.4. Commercial Application
- 8.4.1. Global Vaccine Adjuvants Market, by Commercial Application, by Region, 2020-2034 (USD Million)

9. Global Vaccine Adjuvants Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Vaccine Adjuvants Market Assessment, By Geography, 2020-2034 (USD Million)
9.3. Vaccine Adjuvants Market - North America
- 9.3.1. North America: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
- 9.3.2. North America: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
- 9.3.3. North America: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
- 9.3.4. North America: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.3.5. Vaccine Adjuvants Market - US
  - 9.3.5.1. US: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.3.5.2. US: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.3.5.3. US: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.3.5.4. US: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.3.6. Vaccine Adjuvants Market - Canada
  - 9.3.6.1. Canada: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
9.4. Vaccine Adjuvants Market - Europe
- 9.4.1. Europe: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
- 9.4.2. Europe: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
- 9.4.3. Europe: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
- 9.4.4. Europe: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.5. Vaccine Adjuvants Market - UK
  - 9.4.5.1. UK: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.5.2. UK: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.5.3. UK: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.5.4. UK: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.6. Vaccine Adjuvants Market - France
  - 9.4.6.1. France: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.6.2. France: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.6.3. France: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.6.4. France: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.7. Vaccine Adjuvants Market - Germany
  - 9.4.7.1. Germany: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.8. Vaccine Adjuvants Market - Italy
  - 9.4.8.1. Italy: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.9. Vaccine Adjuvants Market - Spain
  - 9.4.9.1. Spain: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.10. Vaccine Adjuvants Market - Netherlands
  - 9.4.10.1. Netherlands: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.11. Vaccine Adjuvants Market - Russia
  - 9.4.11.1. Russia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.4.12. Vaccine Adjuvants Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
9.5. Vaccine Adjuvants Market - Asia Pacific
- 9.5.1. Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.5. Vaccine Adjuvants Market - China
  - 9.5.5.1. China: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.5.2. China: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.5.3. China: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.5.4. China: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.6. Vaccine Adjuvants Market - India
  - 9.5.6.1. India: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.6.2. India: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.6.3. India: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.6.4. India: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.7. Vaccine Adjuvants Market - Malaysia
  - 9.5.7.1. Malaysia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.8. Vaccine Adjuvants Market - Japan
  - 9.5.8.1. Japan: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.9. Vaccine Adjuvants Market - Indonesia
  - 9.5.9.1. Indonesia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.10. Vaccine Adjuvants Market - South Korea
  - 9.5.10.1. South Korea: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.11. Vaccine Adjuvants Market - Australia
  - 9.5.11.1. Australia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.5.12. Vaccine Adjuvants Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
9.6. Vaccine Adjuvants Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.6.5. Vaccine Adjuvants Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.6.6. Vaccine Adjuvants Market - UAE
  - 9.6.6.1. UAE: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.6.7. Vaccine Adjuvants Market - Israel
  - 9.6.7.1. Israel: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.6.8. Vaccine Adjuvants Market - South Africa
  - 9.6.8.1. South Africa: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.6.9. Vaccine Adjuvants Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
9.7. Vaccine Adjuvants Market - Latin America
- 9.7.1. Latin America: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
- 9.7.2. Latin America: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
- 9.7.3. Latin America: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
- 9.7.4. Latin America: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.7.5. Vaccine Adjuvants Market - Mexico
  - 9.7.5.1. Mexico: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.7.6. Vaccine Adjuvants Market - Brazil
  - 9.7.6.1. Brazil: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.7.7. Vaccine Adjuvants Market - Argentina
  - 9.7.7.1. Argentina: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)
- 9.7.8. Vaccine Adjuvants Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Vaccine Adjuvants Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Vaccine Adjuvants Market, by Route of Administration, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Vaccine Adjuvants Market, by Application, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Vaccine Adjuvants Market, by Disease Type, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. GlaxoSmithKline (GSK)
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Novavax
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Merck & Co.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Sanofi
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. CSL Limited
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Adjuvance Technologies
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. SEPPIC
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Croda International
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Vaxine Pty Ltd
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Brenntag Biosector
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Vaccitech (University of Oxford spin-off)
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Emergent BioSolutions
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Avanti Polar Lipids
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Daiichi Sankyo
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. ImmunoScience
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development

ワクチンアジュバントの世界市場：市場規模・シェア・動向、業界分析 (製品種類別・投与経路別・疾患の種類別・用途別・地域別)、将来予測 (2025年～2034年)

Vaccine Adjuvants Market Size, Share, Trends, Industry Analysis Report: By Product Type, Route of Administration, Disease Type, Application, and Region - Market Forecast, 2025-2034

ワクチンアジュバント市場：分析概要

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章ワクチンアジュバント市場の洞察

第5章世界のワクチンアジュバント市場：製品種類別

第6章世界のワクチンアジュバント市場：投与経路別

第7章世界のワクチンアジュバント市場：疾患の種類別

第8章世界のワクチンアジュバント市場：用途別

第9章世界のワクチンアジュバント市場：地域別

第10章競合情勢

第11章企業プロファイル

List of Tables:

List of Figures:

Vaccine Adjuvants Market Report Highlights

By Product Type Outlook (Revenue - USD Million, 2020-2034)

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

By Disease Type Outlook (Revenue - USD Million, 2020-2034)

By Application Outlook (Revenue - USD Million, 2020-2034)

By Regional Outlook (Revenue - USD Million, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Vaccine Adjuvants Market Insights

5. Global Vaccine Adjuvants Market, by Product Type

6. Global Vaccine Adjuvants Market, by Route of Administration

7. Global Vaccine Adjuvants Market, by Disease Type

8. Global Vaccine Adjuvants Market, by Application

9. Global Vaccine Adjuvants Market, by Geography

10. Competitive Landscape

11. Company Profiles

ワクチンアジュバントの世界市場：市場規模・シェア・動向、業界分析 (製品種類別・投与経路別・疾患の種類別・用途別・地域別)、将来予測 (2025年～2034年)

Vaccine Adjuvants Market Size, Share, Trends, Industry Analysis Report: By Product Type, Route of Administration, Disease Type, Application, and Region - Market Forecast, 2025-2034

ワクチンアジュバント市場：分析概要

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 ワクチンアジュバント市場の洞察

第5章 世界のワクチンアジュバント市場：製品種類別

第6章 世界のワクチンアジュバント市場：投与経路別

第7章 世界のワクチンアジュバント市場：疾患の種類別

第8章 世界のワクチンアジュバント市場：用途別

第9章 世界のワクチンアジュバント市場：地域別

第10章 競合情勢

第11章 企業プロファイル

List of Tables:

List of Figures:

Vaccine Adjuvants Market Report Highlights

By Product Type Outlook (Revenue - USD Million, 2020-2034)

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

By Disease Type Outlook (Revenue - USD Million, 2020-2034)

By Application Outlook (Revenue - USD Million, 2020-2034)

By Regional Outlook (Revenue - USD Million, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Vaccine Adjuvants Market Insights

5. Global Vaccine Adjuvants Market, by Product Type

6. Global Vaccine Adjuvants Market, by Route of Administration

7. Global Vaccine Adjuvants Market, by Disease Type

8. Global Vaccine Adjuvants Market, by Application

9. Global Vaccine Adjuvants Market, by Geography

10. Competitive Landscape

11. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章ワクチンアジュバント市場の洞察

第5章世界のワクチンアジュバント市場：製品種類別

第6章世界のワクチンアジュバント市場：投与経路別

第7章世界のワクチンアジュバント市場：疾患の種類別

第8章世界のワクチンアジュバント市場：用途別

第9章世界のワクチンアジュバント市場：地域別

第10章競合情勢

第11章企業プロファイル